Home > Press > Aculon Innovative Method for Applying Organometallic films to Substrates Receives Patent
Abstract:
Aculon is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a patent covering its method for applying organometallic film to substrates, which has been perfected by the company over the past 6 years.
United States Patent Application No. 11/985,151 discloses the process required for applying an organometallic film on substrates, particularly polymer substrates, in which the metal of the organometallic has "f" orbital electrons. Aculon's novel organometallic films represent a breakthrough in hydrophobic and oleophobic film technology, allowing for a level of hydrophobicity and oleophobicity thought unachievable on numerous substrates.
"We are delighted that our invention has been granted a United States patent. We believe that this approach offers a superior alternative to existing PVD film technologies, offering manufacturers affordable hydrophobic and oleophobic films without the drawbacks associated with traditional film deposition," comments Dr. Eric Hanson, Vice President of Technology.
For more information about Aculon's organometallic film products and technology or details regarding the patent, call the company headquarters at 858-350-9474 or visit Aculon's website at www.aculon.com.
####
For more information, please click here
Copyright © Aculon
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||